Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Akansha Hatewar
Eligibility
Inclusion criteria
Inclusion criteria: 1 Newly diagnosed case of CA breast and biopsy proven. 2 Women aged above 18 years.
Exclusion criteria
Exclusion criteria: 1 Malignancies other than breast carcinoma 2 Pregnancy/puerperium 3 Known c/o Tuberculosis, Chronic inflammatory diseases 4 Patients infected with hepatitis B and C virus as well as H.I.V. 5 Renal/Hepatic insufficiency 6 Metabolic bone disorders 7 No history of medications such as iron, levothyroxine and vitamin D/B12 supplements in the past three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 To estimate levels of serum vit D, Vit B12, and Ferritin in patients with stages of breast cancer. 2 To analyse a correlation between serum vit D, Vit B12, Ferritin with Tumour grade, histopathological subtype and axillary lymph node status. 3 To correlate between serum vit D, Vit B12, and Ferritin with molecular pathological parameters. Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. In this study we aim to conduct a comprehensive analysis by comparing serum expression levels of vitamin B12 vitamin D & ferritin among three distinct groups healthy individuals patients with benign breast conditions & those diagnosed with breast cancer. 2. Our primary focus is to assess the intricate relationship between vitamin B12 vitamin D & ferritin levels & the associated risk of breast cancer. Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Chandrashekhar Mahakalkar
Datta Meghe Institute Of Higher Education And Research
Outcome results
None listed